Tarsus Pharmaceuticals, Inc. logo — company profile

Tarsus Pharmaceuticals, Inc.

Founded 2017 United States Irvine, United States 326 employees Post-IPO Debt Total: $585.60M Biopharma, Biotechnology +1

General Information

Company Name Tarsus Pharmaceuticals, Inc.
Founded Year 2017
Location United States Irvine, United States
Employees 326
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Tarsus Pharmaceuticals, Inc.. To contact Tarsus Pharmaceuticals, Inc., visit tarsusrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tarsus Pharmaceuticals, Inc. compare?

A PDF of Tarsus Pharmaceuticals, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tarsus Pharmaceuticals, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that leverages established science and innovative technology to transform patient care, initially focusing on eye care. Founded in 2017, the company operates within the Biopharma and Biotechnology sectors and is based in the United States. Notably, Tarsus recently secured a significant $100.00MPost-IPO Equity investment on 29 February 2024. This signifies a major milestone in the company's growth and underscores the confidence of the investor community in its potential. With a strong emphasis on pioneering medical solutions, Tarsus Pharmaceuticals, Inc. is poised to make a meaningful impact in the healthcare industry.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $75.00M 2
Pharmakon Advisors, BioPharma Credit
19 Apr 2024
Post IPO Equity $100.00M -
29 Feb 2024
Post IPO Equity $100.00M -
01 Aug 2023
Post IPO Equity $75.60M -
03 May 2022
Post IPO Debt $175.00M 1
Armentum Partners
01 Jan 2022
Series B $60.00M 6
Aperture Venture Partners, Frazier Healthcare Partners +4
08 Jan 2020
Series A Undisclosed -
01 Mar 2018

Tarsus Pharmaceuticals, Inc. Alternatives & Competitors

View All Alternatives
Tarsus Pharmaceuticals, Inc. vs

Advancing the Standard of Care in Ophthalmics

Seed
1 employees
Biopharma, Biotechnology
Tarsus Pharmaceuticals, Inc. vs

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-...

Post-IPO Equity
69 employees
Biopharma, Biotechnology
Tarsus Pharmaceuticals, Inc. vs

On a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin...

Post-IPO Equity
187 employees
Biopharma, Biotechnology

FAQ About Tarsus Pharmaceuticals, Inc.

Tarsus (NASDAQ:TARS) is a biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Tarsus Pharmaceuticals, Inc. was founded in 2017.
Tarsus Pharmaceuticals, Inc. is headquartered in Irvine, United States.
Tarsus Pharmaceuticals, Inc. operates in Biopharma, Biotechnology and Life Sciences.
Tarsus Pharmaceuticals, Inc. has approximately 326 employees.
Tarsus Pharmaceuticals, Inc. has completed 7 funding rounds, raising a total of $585.60M. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Tarsus Pharmaceuticals, Inc. include Visiox Pharmaceuticals, Aadi Bioscience, Inc, DBV Technologies, Geron Corporation, Oxurion NV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tarsus Pharmaceuticals, Inc. and Visiox Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tarsus Pharmaceuticals, Inc., https://bouncewatch.com/company/tarsus-pharmaceuticals-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes